Audited Results & Half Yearly Results

Audited Results

Final Dividend & Audited Results Inter alia, to consider and approve the following: i) the final dividend, if any, on the equity shares of the Company, if any, for the financial year ended March 31, 2020 and recommend the same to the shareholders of the Company; ii) raising funds up-to Rs. 1000,00,00,000/- (Rupees One Thousand Crore only) by way of issue of non-convertible debentures / bonds, medium term notes and other debt securities; and iii) raising funds up-to Rs. 500,00,00,000/- (Rupees Five Hundred Crore only) inter alia by way of issue of securities.

Audited Results

Inter alia, to consider and approve Proposal for increase in borrowing limits from the consortium / other Banks by way of overdraft or cash credit, working capital demand loan, commercial paper, bill discounting, other loan arrangements etc, being temporary / short term loans in the ordinary course of business.

Inter alia, to consider and approve the appointment of Company Secretary & Compliance officer of the Company

Inter alia, to consider and approve the following business activities: 1. To accept the resignation of Mr. Harish Punwani as Company Secretary and Compliance Officer of the Company. 2. To accept the appointment of Mr. Mikil Nitinbhai Gohil as Company Secretary and Compliance Officer of the Company and 3. Any other business with the permission of the Chair.

Audited Results

Inter alia, to consider, among others, the proposal for raising of funds by issue of equity shares, convertible securities or any other securities, including, through a rights issue, preferential issue and/or qualified institutions placement, as may be permitted under applicable law, subject to receipt of regulatory/statutory approvals, as may be required.

Further to its communication dated September 4, 2019, the Company has informed that it has received certified copy of the order issued by the Hon?ble National Company Law Tribunal (NCLT), Mumbai in respect of sanctioning of the Composite Scheme of Amalgamation and Arrangement amongst Max India Limited, Max Healthcare Institute Limited, Radiant Life Care Private Limited and Advaita Allied Health Services Limited and their respective shareholders and Creditors (Scheme). In accordance with the terms of the said Scheme, a meeting of Board of Directors of the Company is scheduled to be held on Monday, June 1, 2020, to take on record the sanction of the said Scheme by Hon'ble NCLT Mumbai Bench and to declare the scheme effective from June 1, 2020. Further, the Board of Directors will also inter-alia consider the record date for determining the shareholders of Max India to whom shares will be allotted by two transferee Companies viz. Advaita Allied Health Services Limited (to be renamed as ?Max India Limited? in terms of the Scheme) and Max Healthcare Instituted Limited, in exchange of shares held by them in Max India Limited in accordance with the Scheme.

Inter alia, to fill up the casual vacancy of Auditor due to the relinquishment of the position by the Statutory Auditors of the Company and also to consider and approve the appointment of new Statutory Auditor as proposed by the Audit Committee of the company until the conclusion of next AGM of the company.

Inter alia, to transact the following business; 1. To consider and approve the re-appointment of Mrs. Bhavna D. Mehta (DIN: 0159095S) as a Managing Director of the Company. 2. To change the designation of Dilectors of company as per amended SEBI (listing obligation and disclosure requirement) Regulation, (if necessary / required). 3. Any other matter with the permission of the Chair.

Inter alia, to consider and approve The Venture into for setting up a solar power plant and to manage, supervise and control the business of transmission of solar power, manufacturing and/or trading in parts of solar power plants, supplying, generation, distribution and dealing in electricity subject to MOA and AOA of the Company.

Audited Results

Final Dividend & Audited Results

Inter alia transact the following businesses: 1. To approve the Annual Report for the financial year ended December 31, 2019 and to consider the date of 26th Annual General Meeting of the Company and other incidental matters. 2. To declare the period during which the register of members and share transfer books of the Company will remain closed for the purpose of the Annual General Meeting for the financial year ended December 31, 2019. 3. To approve the payment of remuneration to Mr. Avirag Jain (DIN: 00004801) as Director & Chief Technology Officer of the Company.

inter alia to transact the following Matters: 1. To consider and accept resignation of the Company Secretary of the Company.

Dividend & Audited Results

Audited Results

Final Dividend & Audited Results

Final Dividend & Audited Results

Preferential Issue of shares & Inter alia, to: 1. Consider allotment of 6,60,000 Equity shares on preferential basis to HT Mobile Solutions Limited (strategic investors not forming part of promoters group). 2. Consider any other business with the permission of Chairman.

Dividend & Audited Results

Increase in Authorised Capital (Revised) & Final Dividend & Audited Results Welspun Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/06/2020 ,inter alia, to consider and approve Due to unavoidable circumstances, the meeting of the board which was scheduled to be held on Fri, May 29, 2020 has been postponed and rescheduled on Mon, June 1, 2020, to consider and approve, inter alia, the following: 1. Standalone as well as consolidated audited financial statements of the Company for the quarter and year ended Mar 31,2020; 2. Recommendation of dividend on equity shares, if any; 3. Increase in authorized share capital; and 4. Raising of funds by issue of equity shares, preference shares, or other securities through a further public offer, qualified institutions placement, rights issue or through any other permissible mode or through a combination thereof, subject to receipt of the necessary approvals including the approval of the shareholders (as applicable) and other regulatory / statutory approvals, as may be required.

Audited Results